Marker Therapeutics Inc (MRKR)

[poods]

I have said if the results aren't fabricated, the company is way undervalued and is a screaming buy at this point. Personally, I have never seen fabrication of clinical results by a biotech company, but I suppose there are examples. More prone to occur with preclinical studies. That said, CRs are CRs and I think someone would end up in jail if what Balyor clinicians have reported is not real.
No - I don't think the data is fabricated and, yes, I think MRKR is way undervalued at this price. I bought more yesterday and will continue adding if it goes down further.
I think it's reasonable to expect a major partnership here. Multi-TAA is the perfect adjuvant treatment. It's active in multiple cancers and it is not physiologically or financially toxic. Just my opinion.